Format

Send to:

Choose Destination

Links from PubMed

Items: 4

1.

Modafinil

A synthetic central nervous system stimulant with wakefulness-promoting activity. Modafinil appears to inhibit dopamine reuptake, resulting in an increase in extracellular dopamine. This agent exhibits pronounced wakefulness-promoting activity (without sympathomimetic activity) and may improve cognitive function in certain clinical settings. (NCI04) [from NCI]

MedGen UID:
32669
Concept ID:
C0066677
Organic Chemical; Pharmacologic Substance
2.

Attention deficit hyperactivity disorder

Attention deficit hyperactivity disorder (ADHD) manifests at age 2-3 years or by first grade at the latest. The main symptoms are distractibility, impulsivity, hyperactivity, and often trouble organizing tasks and projects, difficulty going to sleep, and social problems from being aggressive, loud, or impatient. [from HPO]

MedGen UID:
506017
Concept ID:
CN006126
Finding
3.

Attention deficit hyperactivity disorder

A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V) [from MeSH]

MedGen UID:
220387
Concept ID:
C1263846
Mental or Behavioral Dysfunction
4.

Hyperactivity

Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders. [from MeSH]

MedGen UID:
98406
Concept ID:
C0424295
Finding; Mental or Behavioral Dysfunction
Format

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center